0
0
9/2/22 at 8:01pm
Organization
Cancernetwork.com
42 words
0
Comments
Phillip H. Kuo, MD, PhD, spoke about the future of theragnostic imaging in patients with metastatic castration-resistant prostate cancer.
You are the first to view
https://www.cancernetwork.com/view/phillip-h-kuo-md-phd-evaluates-future-research-surrounding-psma-pet-parameters-and-response-to-177lu-psma-617-in-mcrpc
Create an account
or login to join the discussion